Published in Cancer Lett on January 31, 2014
Let-7, mir-98 and mir-183 as biomarkers for cancer and schizophrenia [corrected]. PLoS One (2015) 1.48
MicroRNA Processing and Human Cancer. J Clin Med (2015) 1.23
Multiple regulation pathways and pivotal biological functions of STAT3 in cancer. Sci Rep (2015) 0.96
Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Mol Pharm (2015) 0.89
Role of miRNA let-7 and its major targets in prostate cancer. Biomed Res Int (2014) 0.89
Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer. Drug Des Devel Ther (2015) 0.85
FXR induces SOCS3 and suppresses hepatocellular carcinoma. Oncotarget (2015) 0.79
Noncoding RNAs and pancreatic cancer. World J Gastroenterol (2016) 0.79
Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins. Front Immunol (2015) 0.78
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Oncotarget (2016) 0.77
Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget (2016) 0.77
The age factor in axonal repair after spinal cord injury: A focus on neuron-intrinsic mechanisms. Neurosci Lett (2016) 0.76
Role of non-coding RNAs in pancreatic cancer: the bane of the microworld. World J Gastroenterol (2014) 0.75
Hedgehog Signaling in Pancreatic Fibrosis and Cancer. Medicine (Baltimore) (2016) 0.75
Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem Cell Res Ther (2017) 0.75
Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics. PLoS One (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 39.31
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med (2011) 24.32
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 19.15
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
Stat3 as an oncogene. Cell (1999) 17.39
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell (2007) 13.69
The STATs of cancer--new molecular targets come of age. Nat Rev Cancer (2004) 13.07
Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (1994) 11.33
The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 11.16
An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell (2009) 10.09
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 9.97
A custom microarray platform for analysis of microRNA gene expression. Nat Methods (2004) 9.44
Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev (2006) 8.26
Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer (2007) 6.57
STATs: signal transducers and activators of transcription. Cell (1996) 6.10
SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol (2003) 4.90
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. J Clin Oncol (2006) 4.70
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene (2007) 4.46
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull (2006) 4.42
Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J (2006) 4.34
let-7 microRNAs in development, stem cells and cancer. Trends Mol Med (2008) 4.29
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res (2009) 4.19
Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol (2007) 4.12
The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer (2010) 3.95
Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (2009) 3.89
Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res (2007) 2.92
miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ (2008) 2.86
Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol (1996) 2.47
Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol (2003) 2.44
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery (2013) 2.43
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res (2011) 2.35
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res (2007) 2.32
EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol (2012) 2.22
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology (2003) 2.16
Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev Dyn (2005) 2.14
How does Lin28 let-7 control development and disease? Trends Cell Biol (2012) 2.09
MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer (2012) 1.90
Stat3 promotes metastatic progression of prostate cancer. Am J Pathol (2008) 1.85
What we have learned about pancreatic cancer from mouse models. Gastroenterology (2012) 1.78
Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res (2010) 1.74
let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther (2009) 1.58
Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Clin Cancer Res (2011) 1.55
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol (2010) 1.45
Genetic alterations in pancreatic carcinoma. Mol Cancer (2003) 1.43
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett (2003) 1.42
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res (2012) 1.25
The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors (2012) 1.13
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood (2011) 1.09
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials. Future Oncol (2013) 1.08
Elevated activity of STAT3C due to higher DNA binding affinity of phosphotyrosine dimer rather than covalent dimer formation. J Biol Chem (2006) 1.08
STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin Ther Targets (2007) 1.05
The expression of microRNA-203 during human skin morphogenesis. Exp Dermatol (2010) 1.04
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation. Br J Cancer (2009) 1.03
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis. Cancer Lett (2012) 1.02
Genomic DNA copy-number alterations of the let-7 family in human cancers. PLoS One (2012) 1.01
The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol (2010) 0.98
Evolution of the let-7 microRNA family. RNA Biol (2012) 0.97
Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link? Front Oncol (2013) 0.95
HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines. Cancer Lett (2011) 0.89
Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. Eur J Surg Oncol (2007) 0.88
Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression. Pancreas (2011) 0.81
Metastatic pancreatic cancer: are we making progress in treatment? Gastroenterol Res Pract (2012) 0.77